News Is J&J approaching the end of its talc litigation hangover? Johnson & Johnson has made a $5.5bn bid to finally bring more than 15 years of litigation over the safety of its talcum powder products to a close.
News J&J's run of talc lawsuit setbacks continues A California jury has awarded $40m in damages to two women who sued Johnson & Johnson, claiming that its talc products caused ovarian cancer.
News J&J faces fresh litigation in UK over talc cancer risks Thousands of people in the UK have joined a lawsuit against Johnson & Johnson, claiming that it knowingly sold talc products that caused cancer.
News J&J on the hook for $966m damages in latest talc lawsuit Johnson & Johnson has suffered a setback in its long-running legal defence against claims its talc products cause cancer.
News Third time not so lucky in J&J's bid to end talc liability Johnson & Johnson's third attempt to use bankruptcy proceedings to settle lawsuits claiming its talc-based products harmed consumers has failed.
News J&J tries to push talc bankruptcy over the line once again Johnson & Johnson's long-running effort to put litigation claiming its talc products caused cancer has continued with a third attempt to place a subsidiary company into bankruptcy.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.